Inventor profile of:

Bernhard GÜNTHER

City:

Dossenheim

Country:

Germany

Published Applications:

29

Last publication date:

2026-04-30

Top Assignees for applications by Bernhard GÜNTHER

The entities that hold a legal rights for patent applications filed by inventor GÜNTHER Bernhard:

Recent patent applications by GÜNTHER Bernhard

Bernhard GÜNTHER from Dossenheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30
US20260115172A1
Human necessities

COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES

#2 | 2026-04-02
US20260091084A1
Human necessities

OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE

#3 | 2025-11-13
US20250345276A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#4 | 2024-10-24
US20240350425A1
Human necessities

COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES

#5 | 2024-07-25
US20240245625A1
Human necessities

OPTHALMIC COMPOSITIONS COMPRISING F6H8

#6 | 2023-12-14
US20230398065A1
Human necessities

OPHTHALMIC COMPOSITIONS COMPRISING LATANOPROST FOR USE IN THE TREATMENT OF OCULAR DISEASES

#7 | 2023-10-19
US20230330056A1
Human necessities

SEMIFLUORINATED ALKANE COMPOSITIONS

#8 | 2023-05-04
US20230139672A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#9 | 2023-02-09
US20230043641A1
Human necessities

OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE

#10 | 2022-07-14
US20220218828A1
Human necessities

TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES

#11 | 2022-03-17
US20220079925A1
Human necessities

COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES

#12 | 2020-11-19
US20200360285A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#13 | 2020-08-27
US20200268682A1
Human necessities

Opthalmic compositions comprising F6H8

#14 | 2020-08-27
US20200268648A1
Human necessities

Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases

#15 | 2020-08-06
US20200246463A1
Human necessities

Semifluorinated alkane compositions

#16 | 2020-07-02
US20200206241A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#17 | 2020-02-27
US20200060987A1
Human necessities

Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions

#18 | 2019-11-14
US20190343793A1
Human necessities

COMPOSITIONS COMPRISING A CANNABINOID RECEPTOR BINDING LIGAND

#19 | 2019-10-31
US20190328717A1
Human necessities

COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES

#20 | 2019-09-12
US20190274970A1
Human necessities

Pharmaceutical compositions for use in the therapy of blepharitis

#21 | 2019-08-08
US20190240234A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#22 | 2019-07-25
US20190224123A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#23 | 2018-12-20
US20180360908A1
Human necessities

OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE

#24 | 2018-11-15
US20180326066A1
Human necessities

Semifluorinated alkane compositions

#25 | 2018-10-25
US20180303849A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#26 | 2018-01-11
US20180008710A1
Human necessities

Liquid pharmaceutical composition for the delivery of active ingredients

#27 | 2017-08-03
US20170216204A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#28 | 2017-06-29
US20170182060A1
Human necessities

Use of semi-fluorinated alkanes in transdermal therapeutic systems

#29 | 2017-05-25
US20170143832A1
Human necessities

Semifluorinated alkane compositions

InventorID:

1882881